Global Biologics CDMO Partner
We champion the missions that matter by partnering with innovators to deliver biologics, cell and gene therapies with the highest standards of quality. Whether you need an end-to-end solution or a specialized CDMO service, our experts provide tailored support—from cell line and viral vector development to drug substance, fill/finish and commercial supply. Backed by advanced technologies, global capacity and decades of proven expertise, we ensure dependable outcomes and trusted partnerships at every stage.
End-to-End Biologics CDMO Services
Biologics
Comprehensive protein biologics development and manufacturing from cell line through to commercial supply.
Gene Therapy
Custom viral vector and plasmid development with scalable manufacturing for advanced gene therapies.
Cell Therapy
Integrated end-to-end solutions with global capacity for autologous and allogeneic therapies.
Specialty
Expertise in advanced modalities, including mRNA, bioconjugates, bispecifics and vaccines.
Why Catalent?
End-to-end CDMO services
Science & scalability
Quality you can trust
Our Biologics team stands apart through the strength of our people, science and partnerships. We bring decades of proven expertise, the industry’s most advanced platforms and a truly global network to solve complex challenges in biologics, cell and gene therapy. More than services, we build true collaboration, flexibility and quality you can trust—ensuring every program is built for long-term success and every therapy moves forward with confidence.
Insights & Expertise
Access tailored insights and expert guidance in biologics, cell and gene therapy to accelerate development and bring treatments to the clinic and market faster.